New Results
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z. Keung, Ming Tang, Liang Yan, Hunain Alam, Guangchun Han, Ayush T. Raman, Christopher Terranova, Sharmistha Sarkar, Elias Orouji, Samir B. Amin, Sneha Sharma, Maura Williams, Neha S. Samant, Mayura Dhamdhere, Norman Zheng, Tara Shah, Amiksha Shah, Jacob B. Axelrad, Nazanin E. Anvar, Yu-Hsi Lin, Shan Jiang, Edward Q. Chang, Davis R. Ingram, Wei-Lien Wang, Alexander Lazar, Min Gyu Lee, Florian Muller, Linghua Wang, Haoqiang Ying, Kunal Rai
doi: https://doi.org/10.1101/507327
Mayinuer Maitituoheti
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Emily Z. Keung
2Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Ming Tang
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Liang Yan
3Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Hunain Alam
3Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Guangchun Han
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Ayush T. Raman
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
4Graduate Program in Quantitative Sciences, Baylor College of Medicine, Houston, TX.
Christopher Terranova
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Sharmistha Sarkar
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Elias Orouji
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Samir B. Amin
5The Jackson Laboratory for Genomic Medicine, Farmington, CT.
Sneha Sharma
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Maura Williams
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Neha S. Samant
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Mayura Dhamdhere
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Norman Zheng
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Tara Shah
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Amiksha Shah
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Jacob B. Axelrad
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Nazanin E. Anvar
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Yu-Hsi Lin
8Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX.
Shan Jiang
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Edward Q. Chang
6Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Davis R. Ingram
7Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Wei-Lien Wang
7Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Alexander Lazar
7Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Min Gyu Lee
3Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Florian Muller
8Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX.
Linghua Wang
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Haoqiang Ying
3Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Kunal Rai
1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Article usage
Posted December 27, 2018.
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z. Keung, Ming Tang, Liang Yan, Hunain Alam, Guangchun Han, Ayush T. Raman, Christopher Terranova, Sharmistha Sarkar, Elias Orouji, Samir B. Amin, Sneha Sharma, Maura Williams, Neha S. Samant, Mayura Dhamdhere, Norman Zheng, Tara Shah, Amiksha Shah, Jacob B. Axelrad, Nazanin E. Anvar, Yu-Hsi Lin, Shan Jiang, Edward Q. Chang, Davis R. Ingram, Wei-Lien Wang, Alexander Lazar, Min Gyu Lee, Florian Muller, Linghua Wang, Haoqiang Ying, Kunal Rai
bioRxiv 507327; doi: https://doi.org/10.1101/507327
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z. Keung, Ming Tang, Liang Yan, Hunain Alam, Guangchun Han, Ayush T. Raman, Christopher Terranova, Sharmistha Sarkar, Elias Orouji, Samir B. Amin, Sneha Sharma, Maura Williams, Neha S. Samant, Mayura Dhamdhere, Norman Zheng, Tara Shah, Amiksha Shah, Jacob B. Axelrad, Nazanin E. Anvar, Yu-Hsi Lin, Shan Jiang, Edward Q. Chang, Davis R. Ingram, Wei-Lien Wang, Alexander Lazar, Min Gyu Lee, Florian Muller, Linghua Wang, Haoqiang Ying, Kunal Rai
bioRxiv 507327; doi: https://doi.org/10.1101/507327
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)